Method and Apparatus for Measuring Thrust
    291.
    发明申请
    Method and Apparatus for Measuring Thrust 审中-公开
    测量推力的方法和装置

    公开(公告)号:US20160202131A1

    公开(公告)日:2016-07-14

    申请号:US14912520

    申请日:2014-08-26

    CPC classification number: G01L1/086 G01H1/10 G01L5/133 G01L25/00

    Abstract: Embodiments of the invention relate to a thrust stand and a method of measuring thrust. Embodiments of the invention pertain to a method of calibrating a thrust stand. Embodiments of the subject thrust stand can incorporate a passive eddy current based damper. Specific embodiments of the passive eddy current based damper can function without contact with the balance arm. Further specific embodiments of the passive eddy current based damper can be used in a vacuum. Embodiments can utilize signal analysis techniques to identify and reduce noise. A logarithmic decrement method can be used to calibrate the thrust stand. Force measurements can be made with embodiments of the subject thrust stand for a standard macroscale dielectric barrier discharge (DBD) plasma actuator and/or other thrust producing devices.

    Abstract translation: 本发明的实施例涉及一种推力支架和一种测量推力的方法。 本发明的实施例涉及一种校准推力支架的方法。 主体推力支架的实施例可以包括基于无源涡流的阻尼器。 基于无源涡流的阻尼器的具体实施例可以在不与平衡臂接触的情况下起作用。 基于被动涡流的阻尼器的其它具体实施例可以在真空中使用。 实施例可以利用信号分析技术来识别和减少噪声。 对数递减方法可用于校准推力支架。 可以利用标准宏观介电阻挡放电(DBD)等离子体驱动器和/或其它推力产生装置的主体推力支架的实施例进行力测量。

    Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies
    292.
    发明授权
    Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies 有权
    使用松弛素来恢复由辅助生殖技术构思的怀孕中的产妇生理学

    公开(公告)号:US09381231B2

    公开(公告)日:2016-07-05

    申请号:US14049620

    申请日:2013-10-09

    Inventor: Kirk P. Conrad

    CPC classification number: A61K38/2221 A61K45/06 A61K2300/00

    Abstract: The subject invention relates to methods for improving a subject's vasculature to normalize maternal hemodynamics, particularly in subjects attempting to conceive via assisted reproductive technologies, and comprises increasing relaxin levels in a subject or increasing any one or more of: relaxin synthesis, relaxin receptor synthesis, relaxin binding to the relaxin receptor, or relaxin receptor activity.

    Abstract translation: 本发明涉及用于改善受试者脉管系统以使母体血液动力学正常化的方法,特别是在试图通过辅助生殖技术设想的受试者中,包括增加受试者中的松弛素水平或增加以下中的一种或多种:松弛素合成,松弛素受体合成, 松弛素结合松弛素受体或松弛素受体活性。

    LOW OHMIC LOSS RADIAL SUPERLATTICE CONDUCTORS
    293.
    发明申请
    LOW OHMIC LOSS RADIAL SUPERLATTICE CONDUCTORS 有权
    低OHMIC损失径向超导体导体

    公开(公告)号:US20160148714A1

    公开(公告)日:2016-05-26

    申请号:US14904457

    申请日:2014-07-11

    Inventor: YONG-KYU YOON

    Abstract: Various examples are provided for low ohmic loss radial superlattice conductors. In one example, among others, a conductor includes a plurality of radially distributed layers that include a non-permalloy core, a permalloy layer disposed on and encircling the non-permalloy core, and a non-permalloy layer disposed on and encircling the permalloy layer. The non-permalloy core and non-permalloy layer can include the same or different materials such as, e.g., aluminum, copper, silver, and gold. In some implementations, the non-permalloy core includes a void containing air or a non-conductive material such as, e.g., a polymer. The permalloy layer can include materials such as, e.g., NiFe, FeCo, NiFeCo, or NiFeMo. In another example, a via connector includes the plurality of radially distributed layers including the permalloy layer and the non-permalloy layer disposed on and encircling the permalloy layer. The via connector can extend through glass, silicon, organic, or other types of substrates.

    Abstract translation: 为低欧姆损耗径向超晶格导体提供了各种实例。 在一个示例中,导体包括多个径向分布的层,其包括非坡莫合金芯,设置在非坡莫合金芯上并围绕非坡莫合金芯的坡莫合金层,以及设置在坡莫合金层上并围绕坡莫合金层 。 非坡莫合金核心和非坡莫合金层可以包括相同或不同的材料,例如铝,铜,银和金。 在一些实施方案中,非坡莫合金芯包括含有空气或非导电材料例如聚合物的空隙。 坡莫合金层可以包括例如NiFe,FeCo,NiFeCo或NiFeMo的材料。 在另一示例中,通孔连接器包括多个径向分布的层,包括坡莫合金层和非坡莫合金层,其设置在坡莫合金层上并包围坡莫合金层。 通孔连接器可以延伸穿过玻璃,硅,有机或其他类型的基板。

    Laterally aligned colloidal nanorods assemblies
    296.
    发明授权
    Laterally aligned colloidal nanorods assemblies 有权
    纵向排列的胶体纳米棒组件

    公开(公告)号:US09291758B2

    公开(公告)日:2016-03-22

    申请号:US14107148

    申请日:2013-12-16

    Abstract: Nanorods assemblies that have lengths in excess of 50 microns to meters are formed from contacting rice-shaped colloidal superparticles that are aligned along the long axis of the colloidal superparticles. The rice-shaped colloidal superparticles are formed from a multiplicity of nanorods with a high degree of association that is end to end to form colloidal superparticles that are in excess of three microns in length and have a length to diameter ratio of about three or more. Methods of preparing the rice-shaped colloidal superparticles employ mixing with an additional ligand to the nanorods to bias the self assembly of the nanorods by solvophobic interactions. Methods of preparing the nanorods assemblies include the infusion of the rice-shaped colloidal superparticles into microchannels patterned on a substrate, wherein the rice-shaped colloidal superparticles' long axes align in the microchannels.

    Abstract translation: 长度超过50微米至米的纳米棒组件由与胶体超细颗粒的长轴对准的米状胶体超细颗粒接触形成。 米状胶体超微粒由具有高度结合关系的多个纳米棒形成,其为端到端形成长度超过3微米且长度与直径之比约为3或更大的胶体超细颗粒。 制备米状胶体超微颗粒的方法使用与纳米棒的另外的配体混合以通过疏解相互作用偏置纳米棒的自组装。 制备纳米棒组件的方法包括将米状胶体超级颗粒注入图案化在基底上的微通道,其中米状胶体超微粒的长轴在微通道中对准。

    POLISHING OF HARD SUBSTRATES WITH SOFT-CORE COMPOSITE PARTICLES
    297.
    发明申请
    POLISHING OF HARD SUBSTRATES WITH SOFT-CORE COMPOSITE PARTICLES 有权
    硬质基材与软核复合颗粒的抛光

    公开(公告)号:US20160060488A1

    公开(公告)日:2016-03-03

    申请号:US14471755

    申请日:2014-08-28

    Abstract: A chemical mechanical polishing (CMP) includes providing a slurry including composite particles dispersed in a water-based carrier that comprise a plurality of hard particles on an outer surface of a soft-core particle. The hard particles have a Mohs hardness at least 1 greater than a Mohs hardness of the soft core particle and/or a Vickers hardness at least 500 Kg/mm2 greater than the soft-core particle. A substrate having a substrate surface with a hardness greater than a Mohs number of 6 or a Vickers hardness greater than 1,000 kg/mm2 is placed into a CMP apparatus having a rotating polishing pad, and CMP is performed with the rotating polishing pad and the slurry to polish the substrate surface.

    Abstract translation: 化学机械抛光(CMP)包括提供包括分散在水性载体中的复合颗粒的浆料,其包含在软核颗粒的外表面上的多个硬颗粒。 硬质颗粒具有比软核颗粒的莫氏硬度至少大1的莫氏硬度和/或比软核颗粒大至少500kg / mm 2的维氏硬度。 将具有大于莫氏数6的维氏硬度大于1000kg / mm2的基板表面的基板放置在具有旋转抛光垫的CMP设备中,并且用旋转抛光垫和浆料进行CMP 抛光衬底表面。

    ORGAN CONSTRUCT AND METHODS OF MANUFACTURE THEREOF
    299.
    发明申请
    ORGAN CONSTRUCT AND METHODS OF MANUFACTURE THEREOF 审中-公开
    有机结构及其制造方法

    公开(公告)号:US20160055264A1

    公开(公告)日:2016-02-25

    申请号:US14783099

    申请日:2014-04-11

    Abstract: Disclosed herein is a method for designing an organ for use in a body of a living being comprising identifying a fluid transport demand of an organ; where the fluid transport demand is the amount of fluid used by the organ to sustain itself and to sustain utility in other organs around it; and where the organ comprises a flow system comprising a network of vessels; determining a spatial density of zones of need in the organ based on a density of normal healthy tissues in the organ; identifying a nature of the flow system; and using constructal principle analysis to generate a design of the organ. Disclosed herein too is an organ manufactured by the aforementioned method.

    Abstract translation: 本文公开了一种用于设计用于生物体内的器官的方法,包括识别器官的流体输送需求; 流体运输需求是器官用于维持自身并维持其周围其他器官的效用的量的量; 并且所述器官包括包括血管网络的流动系统; 基于器官中正常健康组织的密度确定器官中需要的区域的空间密度; 识别流量系统的性质; 并使用建构性原则分析来产生器官的设计。 本文也公开了通过上述方法制造的器官。

    DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION
    300.
    发明申请
    DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION 审中-公开
    卡片蛋白质的交付作为治疗乳腺炎的疗法

    公开(公告)号:US20160017012A1

    公开(公告)日:2016-01-21

    申请号:US14775289

    申请日:2014-03-11

    Abstract: The present invention provides methods and compositions for treating and/or preventing age related macular degeneration and other conditions involving macular degeneration, ocular neovascularization, or ocular inflammation. In an exemplary embodiment, a method is disclosed that involves administering an expression vector that delivers a secretable and cell penetrating CARD to a subject in need of treatment or prevention of age-related macular degeneration or another condition involving macular degeneration or ocular neovascularization.

    Abstract translation: 本发明提供用于治疗和/或预防年龄相关性黄斑变性和涉及黄斑变性,眼新生血管形成或眼部炎症的其它病症的方法和组合物。 在一个示例性实施方案中,公开了一种方法,其涉及向需要治疗或预防年龄相关性黄斑变性或涉及黄斑变性或眼新生血管形成的另一病症的受试者施用递送可分泌和细胞穿透性CARD的表达载体。

Patent Agency Ranking